Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1994-11-08
2000-04-18
Minnifield, Nita
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
4242341, 4242771, 4241921, 4241841, 4242071, A61K 3902, A61K 3938, A61K 3900, A61K 3921
Patent
active
060512377
ABSTRACT:
Vaccines containing recombinant Listeria monocytogenes capable of expressing tumor specific antigens are provided. These vaccines, when administered to a host, are capable of inducing an immune response to the tumor specific antigen. Methods of using these vaccines in the suppression tumor formation are also provided.
REFERENCES:
patent: 4567041 (1986-01-01), Likhite
patent: 4777239 (1988-10-01), Schoolnik et al.
patent: 4816253 (1989-03-01), Likhite
patent: 4879213 (1989-11-01), Fox et al.
patent: 5369008 (1994-11-01), Arlinghause et al.
patent: 5830702 (1998-11-01), Portnoy et al.
patent: 5876735 (1999-03-01), Reed
Webster's Ninth New Collegiate Dictionary, published by Merriam/Webster Inc. see pp. 782 and 783, 1991.
Bast et al. J. Nat. Cancer Inst. 53(3):757-61 1975 (see abstract).
Silverman et al. Mol. Carcinog 3(6):379-86 1990.
Brasseur et al. Int J. Cancer 52:839-41 1992.
Barry et al. Infection and Immunity 60(4):1625-32 1992.
Cohen, J. Science 262:841-843.
Bowie et al. Science 247:1306-1310 1990.
Kumer et al. PNAS 87:1337-1341 1990.
Aggarwal et al., "Oral Salmonella: Malaria Circumsporozoite Recombinants Induce Specific CD8.sup.+ Cytotoxic T Cells," J. Exp. Med. 1990, 172, 1083-1090.
Boon et al., "Tumor Antigens Recognized by T Lymphocytes," Annu. Rev. Immunol. 1994, 12, 337-365.
Camilli et al., "Dual Roles of plcA in Listeria monocytogenes Pathogenesis," Mol. Microbiol. 1993, 8, 143-157.
Cheever et al., "T-Cell Immunity to Oncogenic Proteins Including Mutated RAS and Chimeric BCR-ABL.sup..alpha.," Ann. N.Y. Acad. Sci. 1993, 690:101-112.
Gansbacher et al., "Interleukin 2 Gene Transfer into Tumor Cells Abrogates Tumorigenicity and Induces Protective Immunity," J. Exp. Med. 1990, 172, 1217-1224.
Golumbek et al., "Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4," Science 1991, 254, 713-716.
A. Kruisbeek, Current Protocols in Immunology, John Wiley & Sons, Inc., eds., 1994, V.1, 4.1.1-4.1.2.
Restifo et al., "Identification of Human Cancers Deficient in Antigen Processing," J. Exp. Med. 1993, 177, 265-272.
Schafer et al., "Induction of Cellular Immune response to a Foreign Antigen by a Recombinant Listeria monocytogenes Vaccine," J. Immunol. 1992, 149, 53-59.
Stover et al., "New Use of BCG for Recombinant Vaccines," Nature 1991, 351, 456-460.
Sun et al., "Isolation of Listeria monocytogenes Small-Plaque Mutants Defective for Intracellular Growth and Cell-to-Cell Spread," Infection and Immunity 1990, 58, 3770-3778.
Tilney, L.G. et al, "Actin Filaments and the Growth, Movement, and Spread of the Intracellular Bacterial Parasite, Listeria monocytogenes," J. Cell Bio. 1989 109, 1597-1608.
Townsend et al., "Tumor Rejection after Direct Costimulation of CD8.sup.+ T Cells by B7-Transfected Melanoma Cells," Science 1993, 259, 368-370.
Travis, J., "A Stimulating New Approach to Cancer Treatment," Science 1993, 259, 310-311.
Wirth, R. et al., "Highly Efficient Protoplast Transformation System for Streptococcus faecalis and a New Escherichia coli-S. faealis Shuttle Vector," J. Bacteriol. 1986, 165, 831-836.
Young, J.F. et al., "Cloning and Expression of Influenza Virus Genes", The Origin of Pandemic Influenza Viruses, W.G. Laver, eds., Elsevier Science Publishing Co., Inc., NY, 1983, p. 129.
Minnifield Nita
The Trustees of the University of Pennsylvania
LandOfFree
Specific immunotherapy of cancer using a live recombinant bacter does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific immunotherapy of cancer using a live recombinant bacter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific immunotherapy of cancer using a live recombinant bacter will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2334437